United Therapeutics Corporation
Biotechnology
Healthcare
UTHR
48.40 M shares
NASDAQ US
traded
25 Jun 2025
listed
no
open
290.68
52 week high
410.00
high
290.68
52 week low
276.47
low
284.91
growth
-15.67 %
previous Close
289.94
P/E ratio
45
market cap
16.26 B
div yield
0
usd
Sep 2024
qoq
revenue
749 M
4.76 %
net incoming
309 M
11.15 %
eps
6.39 %
9.23 %
eps surprise
-0.62 %
net profit margin
41.27 %
2.00 %
operating incoming
343 M
7.25 %
net change in cash
198 M
90.21 %
cash on hand
1.55 B
14.62 %
cost of revenue
83.10 M
6.81 %
top top